190 related articles for article (PubMed ID: 36959674)
1. Metabolically healthy obesity is associated with higher risk of both hyperfiltration and mildly reduced estimated glomerular filtration rate: the role of serum uric acid in a cross-sectional study.
Zhang H; Chen R; Xu X; Yang M; Xu W; Xiang S; Wang L; Jiang X; Hua F; Huang X
J Transl Med; 2023 Mar; 21(1):216. PubMed ID: 36959674
[TBL] [Abstract][Full Text] [Related]
2. Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.
Yu S; Yang H; Guo X; Zheng L; Sun Y
Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27240390
[TBL] [Abstract][Full Text] [Related]
3. Sex-Specific Differences in the Association of Metabolically Healthy Obesity With Hyperuricemia and a Network Perspective in Analyzing Factors Related to Hyperuricemia.
Tian S; Liu Y; Feng A; Zhang S
Front Endocrinol (Lausanne); 2020; 11():573452. PubMed ID: 33123092
[TBL] [Abstract][Full Text] [Related]
4. Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese.
Wang C; Liang K; Zhang X; Li C; Yang W; Ma Z; Sun Y; Song J; Lin P; Gong L; Wang M; Liu F; Li W; Xiao J; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Hou X; Chen L
Int Urol Nephrol; 2014 Sep; 46(9):1793-9. PubMed ID: 25099525
[TBL] [Abstract][Full Text] [Related]
5. Association of Metabolically Healthy Obesity and Glomerular Filtration Rate among Male Steelworkers in North China.
Yu M; Zhang S; Wang L; Feng H; Li X; Wu J; Yuan J
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142036
[TBL] [Abstract][Full Text] [Related]
6. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects.
Sesti G; Succurro E; Arturi F; Andreozzi F; Laino I; Perticone M; Sciacqua A; Hribal ML; Perticone F
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):933-40. PubMed ID: 20685093
[TBL] [Abstract][Full Text] [Related]
7. Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese.
Yu S; Guo X; Li GX; Yang H; Zheng L; Sun Y
BMC Nephrol; 2020 Nov; 21(1):505. PubMed ID: 33234109
[TBL] [Abstract][Full Text] [Related]
8. Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study.
Chen Y; Zhang N; Sun G; Guo X; Yu S; Yang H; Zheng L; Sun Y
Obes Res Clin Pract; 2016 Sep; 10 Suppl 1():S84-S95. PubMed ID: 27061989
[TBL] [Abstract][Full Text] [Related]
9. Kidney function in minority children and adolescents with metabolically healthy and unhealthy obesity.
Arora S; Dunkley L; Waldman LM; Chin VL; Umpaichitra V
Clin Obes; 2020 Feb; 10(1):e12345. PubMed ID: 31692279
[TBL] [Abstract][Full Text] [Related]
10. Metabolically healthy obesity and risk of incident CKD.
Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
[No Abstract] [Full Text] [Related]
12. Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
Zheng J; Li X; Zhang Y; Miao Y; Zhang Q
J Transl Med; 2023 Jan; 21(1):39. PubMed ID: 36681819
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia is Associated with the Presence of Metabolically Obese Normal-Weight and Metabolically Healthy Obese Phenotypes.
Guerrero-Romero F; Simental-Mendía LE
Endocr Res; 2022; 47(3-4):124-129. PubMed ID: 35918814
[TBL] [Abstract][Full Text] [Related]
14. Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents.
Genovesi S; Tassistro E; Giussani M; Lieti G; Patti I; Orlando A; Montemerlo M; Antolini L; Parati G
Front Endocrinol (Lausanne); 2022; 13():1006588. PubMed ID: 36246913
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical characteristics of metabolically healthy obese versus metabolically unhealthy obese school children.
Wan Mohd Zin RM; Jalaludin MY; Yahya A; Nur Zati Iwani AK; Md Zain F; Hong JYH; Mokhtar AH; Wan Mohamud WN
Front Endocrinol (Lausanne); 2022; 13():971202. PubMed ID: 36072927
[TBL] [Abstract][Full Text] [Related]
16. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
[TBL] [Abstract][Full Text] [Related]
17. Metabolic obesity phenotypes: a friend or foe of digestive polyps?-An observational study based on National Inpatient Database.
Cheng Y; Han J; Li Q; Shi Y; Zhong F; Wu Y; Wang Z; Yuan Z; Fan X; Zhao J
Metabolism; 2022 Jul; 132():155201. PubMed ID: 35427603
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study.
Hu W; Wu XJ; Ni YJ; Hao HR; Yu WN; Zhou HW
BMC Nephrol; 2017 Jun; 18(1):192. PubMed ID: 28610620
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Metabolic Health and Obesity on Subclinical Target Organ Damage.
Lee HJ; Kim HL; Chung J; Lim WH; Seo JB; Kim SH; Zo JH; Kim MA
Metab Syndr Relat Disord; 2018 Feb; 16(1):46-53. PubMed ID: 29319402
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Prognosis of Acute Myocardial Infarction Associated With Metabolic Health and Obesity Status.
Chew NWS; Kong G; Venisha S; Chin YH; Ng CH; Muthiah M; Khoo CM; Chai P; Kong W; Poh KK; Foo R; Yeo TC; Chan MY; Loh PH
Endocr Pract; 2022 Aug; 28(8):802-810. PubMed ID: 35654337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
